$1.43
-0.11-7.14%
Last update: Nov 3, 4:39 PM
GRI Bio Inc
GRINASDAQ
GRI Bio (GRI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.20 | $-3.17 | $-19.88 | $-31.08 |
| Actual | $-0.91 | $-1.61 | $-0.53 | $-35.84 |
| Surprise | +24.2% | +49.2% | +97.3% | -15.3% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.84 | $-0.83 | $-0.98 | $-0.96 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-0.91 | $-1.20 | 24.2 % |
| Q1 | May 14, 2026 | $-1.61 | $-3.17 | 49.2 % |
| Q4 | Jan 30, 2026 | $-0.53 | $-19.88 | 97.3 % |
| Q3 | Nov 14, 2025 | $-35.84 | $-31.08 | -15.3 % |
